Antonia Salud Salvia

Salazar, R.; Azuara, D.; Vieitez, J. M.; Paez, D.; Santos, C.; Falco, E.; Elez, E.; Lopez Lopez, C.; Valladares-Ayerbes, M.; Robles, L.; Garcia-Alfonso, P.; Buges, C.; Ogaya, G. Duran; Salud Salvia, M. A.; Navarro, V.; Capella, G.; Aranda Aguilar, E.

ULTRA clinical trial: Prospective comparative clinical outcome analysis of three different RAS/BRAF sensitivity mutational cut-offs. A Phase II study of the Spanish TTD Group

ANNALS OF ONCOLOGY 28 -. 01/09/2017.

Porcel, JM; Civit, C; Esquerda, A; Salud, A; Bielsa, S

Utility of CEA and CA 15-3 measurements in non-purulent pleural exudates in the diagnosis of malignancy: A single-center experience

ARCHIVOS DE BRONCONEUMOLOGIA 53 427-431. 01/08/2017.

[doi:10.1016/j.arbres.2016.12.013]

Pineda, E; Salud, A; Vila-Navarro, E; Safont, MJ; Llorente, B; Aparicio, J; Vera, R; Escudero, P; Casado, E; Bosch, C; Bohn, U; Perez-Carrion, R; Carmona, A; Ayuso, JR; Ripolles, T; Bouzas, R; Gironella, M; Garcia-Albeniz, X; Feliu, J; Maurel, J

Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial

TUMOR BIOLOGY 39 -. 16/06/2017.

[doi:10.1177/1010428317705509]

Irigoyen A; Gallego J; Guillén Ponce C; Vera R; Iranzo V; Ales I; Arévalo S; Pisa A; Martín M; Salud A; Falcó E; Sáenz A; Manzano Mozo JL; Pulido G; Martínez Galán J; Pazo-Cid R; Rivera F; García García T; Serra O; Fernández Parra EM; Hurtado A; Gómez Reina MJ; López Gomez LJ; Martínez Ortega E; Benavides M; Aranda E

Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group

EUROPEAN JOURNAL OF CANCER 75 73-82. 01/04/2017.

[doi:10.1016/j.ejca.2016.12.032]

Gasol Cudos, A.; Morales Murillo, S.; Panades Siurana, M. J.; Vilardell Villellas, F.; Canosa Morales, C.; Mele Olive, J.; Iglesias Martinez, E.; Salud Salvia, A.

Change in treatment decisions according to Oncotype Dx Recurrence Score in node positive and negative, estrogen-receptor positive (ER+), HER2 negative breast cancer in a single institution

BREAST 32 92-93. 01/03/2017.

Patel, UB; Brown, G; Machado, I; Santos-Cores, J; Pericay, C; Ballesteros, E; Salud, A; Isabel-Gil, M; Montagut, C; Maurel, J; Ramon-Ayuso, J; Martin, N; Estevan, R; Fernandez-Martos, C

MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial

ANNALS OF ONCOLOGY 28 344-353. 01/02/2017.

[doi:10.1093/annonc/mdw616]

Loupakis F; Stein A; Ychou M; Hermann F; Salud A; Österlund P

A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer

TARGETED ONCOLOGY 11 293-308. 01/06/2016.

[doi:10.1007/s11523-015-0400-y]

Porcel, JM; Esquerda, A; Martinez-Alonso, M; Bielsa, S; Salud, A

Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers A Predictive Multivariate Model

Medicine 95 -. 01/03/2016.

[doi:10.1097/MD.0000000000003044]

Sastre J; Díaz-Beveridge R; García-Foncillas J; Guardeño R; López C; Pazo R; Rodriguez-Salas N; Salgado M; Salud A; Feliu J

Clinical guideline SEOM: hepatocellular carcinoma

CLINICAL & TRANSLATIONAL ONCOLOGY 17 988-995. 01/12/2015.

[doi:10.1007/s12094-015-1451-3]

Fernandez-Martos C; Garcia-Albeniz X; Pericay C; Maurel J; Aparicio J; Montagut C; Safont MJ; Salud A; Vera R; Massuti B; Escudero P; Alonso V; Bosch C; Martin M; Minsky BD

Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial

ANNALS OF ONCOLOGY 26 1722-1728. 01/08/2015.

[doi:10.1093/annonc/mdv223]

Porcel JM; Palma R; Bielsa S; Esquerda A; Gatius S; Matias-Guiu X; Salud A

TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions

RESPIROLOGY 20 831-833. 01/07/2015.

[doi:10.1111/resp.12543]

Porcel JM; Gasol A; Bielsa S; Civit C; Light RW; Salud A

Clinical features and survival of lung cancer patients with pleural effusions

RESPIROLOGY 20 654-659. 01/05/2015.

[doi:10.1111/resp.12496]